Literature DB >> 1717123

Soluble interleukin-2 receptors and other markers in primary lung cancer.

N Poulakis1, A Sarandakou, D Rizos, I Phocas, T Kontozoglou, D Polyzogopoulos.   

Abstract

Serum levels of soluble interleukin-2 receptors (sIL-2R), carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), beta-chorionic gonadotropin (beta-HCG), pregnancy-specific glycoprotein (SP1), and beta 2-microglobulin (beta 2M) were taken in 92 patients with primary lung cancer and 43 controls. The mean value of sIL-2R in the cancer group was twice as high as that of the controls (P less than 0.001) and the highest values were observed in those with small cell carcinoma (SCC) (P less than 0.0001). Of the cancer patients, 51.1% had CEA values higher than the cutoff level of 5 ng/ml. Extended-disease patients had a higher percentage of increased CEA values than those with limited disease. Adenocarcinoma (ADCC) and SCC groups had the highest percentages of increased CEA levels. There was no significant difference between the groups for beta-HCG, AFP, SP1, and beta 2M, and intermarker correlation was not seen. The results suggest that sIL-2R and CEA may be useful in monitoring the extent of disease and possibly indicate the histologic subtype, thus having a bearing on treatment and prognosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717123     DOI: 10.1002/1097-0142(19910901)68:5<1045::aid-cncr2820680523>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.

Authors:  Miao Yu; Yun-Hong Wang; Ahmed M E Abdalla; Wen-Qi Liu; Fei Mei; Jian Wang; Chen-Xi Ouyang; Yi-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

2.  Levels of serum-soluble receptor for interleukin-2 in patients with colorectal cancer.

Authors:  H Saito; S Tsujitani; K Katano; M Ikeguchi; M Maeta; N Kaibara
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

3.  The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanoma.

Authors:  T Palomares; P Bilbao; A Alonso-Varona; E Barberá-Guillem
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

4.  Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.

Authors:  P L Cheah; C K Liam; S F Yap; L M Looi
Journal:  J Clin Pathol       Date:  1994-06       Impact factor: 3.411

5.  Cytokine soluble receptors in perinatal and early neonatal life.

Authors:  Efthimia Protonotariou; Demetrios Rizos; Ariadne Malamitsi-Puchner; Evangelia Moira; Angeliki Sarandakou; Emmanuil Salamalekis
Journal:  Mediators Inflamm       Date:  2003-06       Impact factor: 4.711

6.  Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.

Authors:  B Nakata; K H Chung; Y Kato; Y Yamashita; A Inui; Y Arimoto; K Maeda; N Onoda; T Sawada; M Sowa
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

7.  Biological significance of soluble IL-2 receptor.

Authors:  C Caruso; G Candore; D Cigna; A T Colucci; M A Modica
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.